| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 65 955 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5 625 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5 625 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 8 394 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8 394 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 16 150 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 16 150 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 8 075 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8 075 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 2 406 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 4 156 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 9 444 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 16 150 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 6 250 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11 250 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 20 853 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 15 114 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 12 086 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 21 750 | — | deriv |
| 28 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 16 150 | 0.00 USD | |
| 22 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 2 064 | 21.77 USD | |
| 20 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 726 | 19.79 USD | |
| 13 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 873 | 22.19 USD | |
| 15 sept. 2025 | SALE | Apellis Pharmaceuticals, Inc. | 189 | 24.19 USD | |
| 02 sept. 2025 | SALE | Apellis Pharmaceuticals, Inc. | 548 | 28.08 USD | |